Belatacept 250mg powder for solution for infusion vials

SNOMED code
19464711000001108
Active compound
Belatacept
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
1 vial, vial
Ingredients
Belatacept — 250 mg based on ingredient substance
Form & Route
solutioninfusion.intravenous
Powder for solution for infusion, Intravenous
Controlled drug
No Controlled Drug Status

Products

Nulojix 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd)

in short Nulojix 250mg pdr for concentrate for inf vials

Nulojix 250mg powder for concentrate for solution for infusion vials

SNOMED code
19463411000001100
Supplier
Bristol-Myers Squibb Pharmaceuticals Ltd
Licensed as
Medicines - MHRA/EMA
Availability restrictions
None
Licensed route
Intravenous
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Nulojix 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) 2 vial
19463611000001102   ref. pack		 Discontinued


Legal category: POM		5012712004066

End: 05012712004066
NHS Indicative Price
£709.4		• Personally Administered
• Hospital
  • • Prescription Charges
  • • Dispensing Fees
  • • Broken Bulk
  • • Discount not deducted - automatic
 —
Nulojix 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) 1 vial
19463511000001101   ref. pack		💯 Available

Legal category: POM		5012712004059

End: 05012712004059
NHS Indicative Price
£354.52		• Personally Administered
• Hospital
  • • Prescription Charges
  • • Dispensing Fees
  • • Special container
  • • Discount not deducted - automatic
 —

Reference packs

Belatacept 250mg powder for solution for infusion vials 1 vial
SNOMED code
19463211000001104
Quantity and unit
1 vial
Packs
Belatacept 250mg powder for solution for infusion vials 2 vial
SNOMED code
19463311000001107
Quantity and unit
2 vial
Packs